Literature DB >> 6319888

Down-regulation of delta but not mu opioid receptors in the hippocampal slice associated with loss of physiological response.

R Dingledine, R J Valentino, E Bostock, M E King, K J Chang.   

Abstract

In rat hippocampal slices, opioids potentiate the synaptic activation of pyramidal neurons as revealed by the shift to the left in the input-output curve constructed by plotting the population spike as a function of the field EPSP. The peak effect was obtained within 12-25 min with D-Ala2,D-Leu5-enkephalin (DADLE), morphiceptin and morphine. However, the effect of both peptides declined during constant superfusion. About 60% peak effect was lost after 1 hr superfusion with morphiceptin or after 4 hr with DADLE. In contrast, the effect of morphine gradually increased over a 4 hr incubation. Following superfusion of the slices for 4 hr in DADLE or morphine, or 1.5 hr in morphiceptin, the membrane particulate fractions were prepared from the homogenate of slices. Opiate receptor binding activities were measured with 125I-DADLE (delta-receptors) and 125I-FK 33824 (mu-receptors). A significant reduction in delta- but not mu-receptor binding was detected in slices treated with DADLE. This seems to correlate to the development of desensitization to DADLE. Neither mu-receptor nor delta-receptor binding activity was altered by the superfusion of morphine or morphiceptin despite the development of desensitization to morphiceptin. These data suggest that there are differences in the regulation of mu- and delta-receptors in hippocampus. The down-regulation of delta-receptors may result in desensitization to delta-agonists and a different mechanism may be responsible for desensitization to mu-agonists.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6319888     DOI: 10.1016/0024-3205(83)90510-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Impact of calcium-activated potassium channels on NMDA spikes in cortical layer 5 pyramidal neurons.

Authors:  Tobias Bock; Greg J Stuart
Journal:  J Neurophysiol       Date:  2016-03-02       Impact factor: 2.714

2.  Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.

Authors:  T V Dunwiddie; K J Johnson; W R Proctor
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

3.  Down-regulation of 3H-lofentanil binding to opiate receptors in different cultured neuronal cells.

Authors:  J M Maloteaux; J N Octave; E C Laterre; P M Laduron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Buprenorphine differentially alters opioid receptor adaptation in rat brain regions.

Authors:  M M Belcheva; M T Ho; E G Ignatova; L B Jefcoat; J Barg; Z Vogel; R J McHale; F E Johnson; C J Coscia
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

Review 5.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

6.  Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit.

Authors:  J D Tobias; J K Deshpande; D F Gregory
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

7.  Enhanced development of morphine tolerance in rats treated with 2-deoxy-D-galactose.

Authors:  P Richter; W Pohle; G Grecksch; K H Smalla; R Jork; H Matthies
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.